Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Haluska

Showing results (11-20 of 403) with videos related to

Pageof 41
Sort By:
Journal of Mammary Gland Biology and Neoplasia|November 22, 2008
IGF-1 receptor inhibitors in clinical trials--early lessonsS John Weroha, Paul Haluska
Current Opinion in Investigational Drugs (London, England : 2000)|September 25, 2009
Resistance pathways relevant to insulin-like growth factor-1 receptor-targeted therapyAndrea Wahner Hendrickson, Paul Haluska
Expert Opinion on Investigational Drugs|June 25, 2009
CixutumumabKevin P McKian, Paul Haluska
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 13, 2006
Genetic alterations in signaling pathways in melanomaFrank G Haluska, Hensin Tsao, Helen Wu, et al.
Endocrinology and Metabolism Clinics of North America|June 12, 2012
The insulin-like growth factor system in cancerS John Weroha, Paul Haluska
Current Oncology Reports|August 12, 2006
Therapeutic targets in melanoma: map kinase pathwayFrank G Haluska, Nageatte Ibrahim
Epilepsy Research|January 1, 1987
Prophylaxis of amygdala kindling-induced epileptogenesis: comparison of a GABA uptake inhibitor and diazepamW S Schwark, M Haluska
Physical Review. B, Condensed Matter|July 1, 1994
Experimental observation of static disorder in C60 by diffuse neutron scatteringGlas, Blaschko, Krexner, et al.
Physical Review. B, Condensed Matter|November 15, 1993
Heterophase fluctuations near the 260-K transition and the absence of reflections with half-integer indices in a C60 single crystalBlaschko, Glas, Maier, et al.
Current Opinion in Investigational Drugs (London, England : 2000)|January 31, 2002
Receptor tyrosine kinase inhibitorsP Haluska, A A Adjei
Pageof 41

Showing results (11-20 of 403) with videos related to

Sort By:
Pageof 41
Journal of Mammary Gland Biology and Neoplasia|November 22, 2008
IGF-1 receptor inhibitors in clinical trials--early lessonsS John Weroha, Paul Haluska
Current Opinion in Investigational Drugs (London, England : 2000)|September 25, 2009
Resistance pathways relevant to insulin-like growth factor-1 receptor-targeted therapyAndrea Wahner Hendrickson, Paul Haluska
Expert Opinion on Investigational Drugs|June 25, 2009
CixutumumabKevin P McKian, Paul Haluska
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 13, 2006
Genetic alterations in signaling pathways in melanomaFrank G Haluska, Hensin Tsao, Helen Wu, et al.
Endocrinology and Metabolism Clinics of North America|June 12, 2012
The insulin-like growth factor system in cancerS John Weroha, Paul Haluska
Current Oncology Reports|August 12, 2006
Therapeutic targets in melanoma: map kinase pathwayFrank G Haluska, Nageatte Ibrahim
Epilepsy Research|January 1, 1987
Prophylaxis of amygdala kindling-induced epileptogenesis: comparison of a GABA uptake inhibitor and diazepamW S Schwark, M Haluska
Physical Review. B, Condensed Matter|July 1, 1994
Experimental observation of static disorder in C60 by diffuse neutron scatteringGlas, Blaschko, Krexner, et al.
Physical Review. B, Condensed Matter|November 15, 1993
Heterophase fluctuations near the 260-K transition and the absence of reflections with half-integer indices in a C60 single crystalBlaschko, Glas, Maier, et al.
Current Opinion in Investigational Drugs (London, England : 2000)|January 31, 2002
Receptor tyrosine kinase inhibitorsP Haluska, A A Adjei
Pageof 41